The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we save that for usually for older women who have a very small tumor uh and when I say older women it's it's more because of the fact that u the remainder of the breast remains untreated so a local recurrence is a little bit more likely in someone that has not had full breast radiation but in a selected subopul of small breast cancers in someone with a very large breast you can do partial breast where you're only targeting the lumpctomy cavity
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.